Plunkett Research Online: Genocea Biosciences Inc

GENOCEA BIOSCIENCES INC (GNCA:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Genocea Biosciences, Inc. is a biopharmaceutical company that seeks to discover and develop novel cancer immunotherapies. Genocea uses its proprietary ATLAS (antigen lead acquisition system) discovery platform ATLAS to profile CD4+ and CD8+ T-cell (cellular) immune responses to tumor antigens. The.....



Genocea Biosciences Inc
Ticker: GNCA
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 617-876-8191
Fax: 617-876-8192
Address: 100 Acorn Park Drive
Cambridge, MA 02140 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Vaccine Research
ContactsDescription

William ClarkCEO/Director/President
Diantha DuvallCFO/Chief Accounting Officer
See More
Genocea Biosciences, Inc. is a biopharmaceutical company that seeks to discover and develop novel cancer immunotherapies. Genocea uses its proprietary ATLAS (antigen lead acquisition system) discovery platform ATLAS to profile CD4+ and CD8+ T-cell (cellular) immune responses to tumor antigens. The.....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201920182017201620152014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
ATLAS
GEN-009
GEN-011
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: